Brock University's 2015 3MT finalists
Brock’s Three Minute Thesis (3MT®) finals were held last month as part of the 10th annual Mapping the New Knowledges Graduate Student Research Conference.
The 3MT® contest encourages students to talk about their research and explain why it matters in a way that will inform and captivate people outside of their disciplines. The challenge is that this must be accomplished in three minutes or less, while using only one PowerPoint slide.
Watch all of the videos from the five finalists listed below by CLICKING HERE
2015 Brock champion: Matthew Nikitczuk, St. Catharines (Master’s student, Earth Sciences)
Matthew’s research focuses on a particular type of micro-fossil that eats volcanic glass. The implications of the study allow for new insight into early life on earth, as well as beyond it.
2015 Brock runner-up: Natalie Trojanowski, Niagara Falls (Master’s student, Health Sciences)
Natalie’s presentation focuses on the inefficiency of a specific protein within those suffering from muscular dystrophy. She will highlight how diet could be used to improve the efficiency of the protein and as a result conserve muscle strength in muscular dystrophy patients.
2015 Brock finalist: Hasam Madarati, Mississauga (Master’s student, Biotechnology)
Hasam’s research focuses on studying wet, water-filled cells in the body responsible for transferring protein from one cell to another. He hopes to use this to better understand the intake of fatty foods and keep people healthy.
2015 Brock finalist: Emma Stares, Wellington, New Zealand (PhD student, Chemistry)
Emma will present on improved MRI scans and her proposal to develop a new family of contrast agents that are safer for patients and will produce more early and accurate disease diagnosis.
2015 Brock finalist: Mikel Ghelfi, Trimbach, Switzerland (PhD student, Chemistry)
Mikel is focusing on Vitamin E. Specifically, he will highlight a Vitamin E analogue he created that offers new insight into the movement and interaction the protein has with the cell membrane. The analogue is already gaining interest from brain disease researchers.
